[Edaily Reporter Kwon Oh Seok ] Gencurix Inc.(229000) shares are showing strength in early trading. Buying interest appears to be surging following news that the company has been selected for a government-funded project worth approximately 30 billion won. According to MP Doctor on the 17th, Gencurix Inc. is trading at 2,445 won as of 9:28 a.m., up 6.30% from the previous trading day. The previous day, the company announced in a regulatory filing that it had been selected for the “2026 First Round of Newly Supported Projects for the Inter-Ministerial Advanced Medical Device R&D Program,” organized by the Inter-Ministerial Medical Device R&D Project Group. Gencurix Inc. has signed an agreement to serve as a joint R&D partner for the project titled “Development of a Next-Generation Digital PCR Integrated Platform for Early Screening of Major Cancers.” The project period runs from April 1, 2026, to December 31, 2032, with a total budget of 29,383,740,000 won.
As NVIDIA achieved record-high revenue for the 13th consecutive quarter, the company once again emphasized its collaboration with major memory manufacturers such as SamsungElectronics and SK hynix. Th…
#Shinsegae Co.,Ltd is accelerating the final stages of the spin-off involving siblings Chung Yong-jin and Chung Yu-kyung. Since establishing an independent management structure for the siblings in 201…
(Courtesy of SamsungElectronics)
SamsungElectronics(005930)unveiled the “Galaxy S26 FE (Fan Edition)” on the 27th, a device that incorporates a well-rounded selection of flagship features. This ne…